Physician profile

Paul C Zei

Cardiovascular Disease · Boston, MA

NPI 1528100500

$785,512.29

in general payments reported to CMS, 2019-2025

14 companies · $70K in 2025

The $70K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$158,218.62
Acquisitions$103,770.72
Travel and Lodging$54,110.05
Food and Beverage$3,538.79

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $414,903.54 2022-2025 Micra, Affera Mapping System
Biosense Webster, INC. $134,354.24 2019-2025 Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter
Medical Device Business Services, INC. $131,676.99 2019-2024 Carto 3
Volta Medical INC $43,798.64 2022-2025 Vx1
Abbott Laboratories $36,656.88 2019-2025 Ensite, Tacticath Ablation Catheter, Sensor Enabled, Perclose Proglide
Siemens Medical Solutions USA, INC. $12,054.32 2023
Varian Medical Systems, INC. $6,400.00 2020
Baylis Medical Company INC $4,275.00 2021
Boston Scientific Corporation $560.52 2022-2025 Emblem Mri S-Icd, Watchman Access System
Altathera Pharmaceuticals LLC $500.00 2021
Biotronik INC. $190.08 2022-2023
Irhythm Technologies, INC. $89.14 2024 Zio Monitor, Zio Xt Patch
Cardiva Medical, INC. $28.98 2025 Cardiva Vascade Mvp Xl Vvcs 10-12f
Medtronic Vascular, INC. $23.96 2019-2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Paul C Zei

$785,512.29

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $70K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/890519/paul-c-zei

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.